Effect of AF, olaparib and aurola treatment on immune-related
4.6 (73) · $ 13.99 · In stock
Olaparib alone or in combination with anti-PD-L1 alters frequency of
Antioxidants, Free Full-Text
From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer, Journal of Ovarian Research
Current and future strategies for the treatment of ES-SCLC
Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism
Cancers, Free Full-Text
Antioxidants, Free Full-Text
SEC Filing - Mersana Therapeutics
Small molecule inhibitors targeting the cancers - Liu - 2022 - MedComm - Wiley Online Library
Laurie FREIRE BOULLOSA, PhD Student
Effect of AF, olaparib and aurola treatment on immune-related
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer
ASCO GU 2023: Final Overall Survival in PROpel: Abiraterone and Olaparib Versus Abiraterone and Placebo as First-Line Therapy for mCRPC
Antioxidants, Free Full-Text
Full article: Current Molecular and Clinical Landscape of ATRT – The Link to Future Therapies
